Cardiovascular disease medications underused globally
Secondary prevention medications for cardiovascular diseases (CVD) are underused globally and additional strategies to increase their use are needed to...
adminph
Aplagon secures EUR 7 million for APAC phase 2a trials
Funding led by new investors FSG and EIC Fund Helsinki-based Aplagon has raised EUR 7 million to advance its APAC...
CHMP recommends SC Rybrevant for EGFR-mutated NSCLC patients
Positive opinion issued for marketing authorisation extension The Committee for Medicinal Products for Human Use (CHMP) has recommended extending marketing...
Gene therapy may be “one shot stop” for rare bone disease
For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that must...
Researchers identify genetic 'fingerprint' to predict drug resistance in bacteria
Antibiotic resistance is a global public health crisis responsible for more than a million deaths annually. By 2050, the World...
